U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07527221) titled 'Safety and Tolerability of ZE74-0282 in Healthy Volunteers' on March 23.
Brief Summary: A first-in-human study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses under fasted and fed conditions of ZE74-0282 administered orally in healthy volunteers.
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: ZE74-0282-0001 or placebo
The participant will receive ZE74-0282-0001 or placebo
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Eilean Therapeutics AU Pty Ltd
Published by HT Digital Content Services with permission from Health Dail...